Glycated Hemoglobin Testing Equipment Market 2028 By Product Type, Technology, End User and Geography | The Insight Partners

report image

Glycated Hemoglobin Testing Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Multifunctional Testing Equipment, Simple Testing Equipment); Technology (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassay, Direct Enzymatic Assay, Boronate Affinity Chromatography, Others); End User (Hospitals, Research Institutions, Physical Examination Institutions, Others) and Geography

Report Code: TIPRE00024865 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Glycated hemoglobin testing is a type of test used to determine individuals' three-month average blood glucose level to understand whether diabetes is controlled or not. It indicates the amount of glucose present in a person's blood in the past two to four months. The test is used to treat diabetes and detect prediabetes via monitoring the amount of hemoglobin bound to glucose. The test helps in the diagnosis of early heart disease and stroke.


The "Global Glycated Hemoglobin Testing Equipment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the glycated hemoglobin testing equipment market with detailed market segmentation by product type, technology, end user, and geography. The report provides key statistics on the market status of the leading glycated hemoglobin testing equipment market players and offers key trends and opportunities in the market.


  •  Based on product type, the global glycated hemoglobin testing equipment market is segmented into multifunctional testing equipment and simple testing equipment.
  •  Based on technology, the market is segmented into ion-exchange high performance liquid chromatography (HPLC), immunoassay, direct enzymatic assay, boronate affinity chromatography and others.
  •  On the basis of end-users, the market is bifurcated into hospitals, research institutions, physical examination institutions and others.


  •  Rise in the prevalence of diabetes worldwide.
  •  Increase in the geriatric population.
  •  Technological advancements in diabetes diagnostic equipment.
  •  Poor diet & sedentary lifestyle resulting in substandard healthcare conditions.
  •  Growing R&D activities on diabetes.


  •  Lack of awareness associated with diabetic care.
  •  High costs of glycated hemoglobin testing devices.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The glycated hemoglobin testing equipment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the glycated hemoglobin testing equipment market in these regions.


COVID-19 initially began in Wuhan (China) in December 2019, and till now, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected economies and industries in different countries due to lockdowns, travel bans, and business shutdowns. The shutdown of plants and factories affected the worldwide supply chains and negatively impacted the glycated hemoglobin testing equipment market's manufacturing, delivery schedules, and sales of products. Few companies had announced delays in their product deliveries and a decrease in future sales. Hence, owing to the factors mentioned above, the pandemic has affected the growth of the market in the forecast period.

Get more information on this report :


The report covers key developments in the glycated hemoglobin testing equipment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from glycated hemoglobin testing equipment market are anticipated to have lucrative growth opportunities in the future with the rising demand for glycated hemoglobin testing equipment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the glycated hemoglobin testing equipment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Abbott Laboratory
  •  Bio-Rad Laboratories, Inc.
  •  Randox Laboratory Ltd
  •  Beckman Coulter, Inc.
  •  EKF Diagnostics
  •  A.Menarini Diagnostics Ltd
  •  F Hoffmann-La Roche Ltd
  •  Tosoh Corporation
  •  Bayer
  •  Alere Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Abbott Laboratory
2. Bio-Rad Laboratories, Inc.
3. Randox Laboratory Ltd
4. Beckman Coulter, Inc.
5. EKF Diagnostics
6. A.Menarini Diagnostics Ltd
7. F Hoffmann-La Roche Ltd
8. Tosoh Corporation
9. Bayer
10. Alere Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount